Metastatic Colorectal Cancers Recruiting Phase 1 Trials for Cetuximab (DB00002)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03356158A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal CancerTreatment